-
Signature
-
/s/ Erin Guldiken, attorney-in-fact for Javier Olivan
-
Issuer symbol
-
META
-
Transactions as of
-
30 Jun 2025
-
Net transactions value
-
-$383,083
-
Form type
-
4
-
Filing time
-
02 Jul 2025, 18:43:17 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Olivan Javier |
Chief Operating Officer |
C/O META PLATFORMS, INC., 1 META WAY, MENLO PARK |
/s/ Erin Guldiken, attorney-in-fact for Javier Olivan |
02 Jul 2025 |
0001564475 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
META |
Class A Common Stock |
Sale |
$9,597 |
-13 |
-0.16% |
$738.26 |
8,357 |
30 Jun 2025 |
Direct |
F1, F2 |
| transaction |
META |
Class A Common Stock |
Sale |
$129,465 |
-175 |
-2.1% |
$739.80 |
8,182 |
30 Jun 2025 |
Direct |
F1, F3 |
| transaction |
META |
Class A Common Stock |
Sale |
$225,415 |
-304 |
-3.7% |
$741.50 |
7,878 |
30 Jun 2025 |
Direct |
F1, F4 |
| transaction |
META |
Class A Common Stock |
Sale |
$18,604 |
-25 |
-0.32% |
$744.17 |
7,853 |
30 Jun 2025 |
Direct |
F1 |
| holding |
META |
Class A Common Stock |
|
|
|
|
|
8,622 |
30 Jun 2025 |
By Olivan D LLC |
F5 |
| holding |
META |
Class A Common Stock |
|
|
|
|
|
2,999 |
30 Jun 2025 |
By Olivan Reinhold D LLC |
F6 |
| holding |
META |
Class A Common Stock |
|
|
|
|
|
8,622 |
30 Jun 2025 |
By Reinhold D LLC |
F7 |
| holding |
META |
Class A Common Stock |
|
|
|
|
|
90,493 |
30 Jun 2025 |
By Olivan Reinhold Family Revocable Trust u/a/d 10/16/12 |
F8 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: